跳至主要内容
临床试验/NCT06569953
NCT06569953招募中4 期

Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chronic Pain After Thoracoscopic Pneumonectomy: A Multicenter, Randomized, Double-blind, Controlled Clinical Trial

The Second Affiliated Hospital of Chongqing Medical University1 个研究点 分布在 1 个国家目标入组 284 人开始时间: 2024年8月26日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
284
试验地点
1
主要终点
The incidence of chronic postoperative pain

研究概览

简要总结

The goal of this clinical trial is to evaluate the efficacy and safety of liposomal Bupivacaine administered by paravertebral block for the treatment of acute and chronic pain after video-assisted thoracoscopic lobectomy.

详细描述

Researchers will compare liposomal bupivacaine to bupivacaine to see if liposomal bupivacaine works better to treat acute and chronic pain after video-assisted thoracoscopic lobectomy.Participants will:1.Received liposomal bupivacaine or bupivacaine paravertebral block before surgery. 2.Keep a diary of their pain scores within 30min after recovery from anesthesia and 6h, 12h, 24h, 48h, 72h and 90d after the beginning of injection of experimental drugs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants who scheduled for elective video-assisted thoracoscopic lobectomy under general anesthesia.
  • Participants were 18 years or older.
  • 18 kg/m2≤BMI≤30 kg/m2
  • Participants with American Society of Anesthesiology (ASA) physical status I-III.
  • Understand the significance, possible benefits, potential risks of the trial in detail.Understand the procedures and methods of this study.Willing to complete the trial in strict compliance with the clinical trial protocol.Sign the informed consent form voluntarily.

排除标准

  • with severe cardiovascular and cerebrovascular diseases such as myocardial infarction,unstable angina pectoris,severe cardiac rhythm disorders (second- and third-degree heart block,etc.), New York Heart Association (NYHA) functional class III/IV,Ischemic stroke.
  • with psychiatric disorders (such as schizophrenia,depression,etc.) and cognitive impairment.
  • with sensory disorders such as hyperalgesia.
  • with other bodily pain.
  • allergy to amide-type local anesthetics or any of the trial drugs
  • taking drugs that affect liver metabolism,corticosteroids,benzodiazepines,non-steroidal anti-inflammatory drugs(NSAIDs),opioid agonist-antagonist,central-alpha 2-agonists,anticonvulsants,antidepressants within 72h.
  • with a history of alcohol or opioid abuse.
  • who were pregnant or lactating.
  • who were currently included in another clinical study within 3 months.

研究组 & 干预措施

intervention (liposomal bupivacaine)

Experimental

Participants randomized to the intervention arm received liposomal bupivacaine for paravertebral block before surgery.

干预措施: Liposomal bupivacaine (Drug)

control (bupivacaine hydrochloride)

Active Comparator

Participants randomized to the intervention arm received bupivacaine hydrochloride for paravertebral block before surgery.

干预措施: Bupivacaine Hydrochloride (Drug)

结局指标

主要结局

The incidence of chronic postoperative pain

时间窗: postoperative day (POD) 90

The incidence of chronic postoperative pain at 90 days

Area under the movement-evoked pain intensity-time curve

时间窗: from 0-72 hours after the intervention

Area under the pain intensity-time curve in the movement (or coughing) state within 72h after the intervention.

次要结局

  • Area under the rest pain intensity-time curve(from 0-72 hours after the intervention)
  • Movement-evoked pain score(30 minutes after recovery from anesthesia,6 hours, 12hours, 24hours , 48hours and 72 hours after the intervention)
  • Proportion of participants who did not use rescue analgesia(from 0-72 hours after the intervention)
  • Score of satisfaction with analgesia(At 72 hours after the intervention)
  • The cumulative dosage of rescue analgesia(from 0-72 hours after the intervention)
  • Length of hospital stay(From date of surgery until the date of first hospital discharge,assessed up to 1 months)
  • Chronic pain score(postoperative day (POD) 90)
  • Pain score at rest(30 minutes after recovery from anesthesia,6 hours,12hours, 24hours , 48hours and 72 hours after the intervention)
  • The time of first use of rescue analgesia(from 0-72 hours after the intervention)
  • First time out-of-bed(From date of surgery until the date of first out-of-bed,assessed up to 7 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验